+143.3%
MRNA vs AVTR
+84.8%
+58.4%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | AVTR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -2.4% | -0.9% | -1.0% |
| 7D | -10.1% | +1.6% | -11.6% | -11.7% |
| 30D | +126.7% | +8.4% | +118.4% | +108.3% |
| 3M | +184.1% | +50.2% | +134.0% | +120.7% |
| 6M | +143.3% | +82.6% | +60.7% | +71.2% |
| All | +143.3% | +84.8% | +58.4% | +71.2% |
Cumulative growth
Daily Returns
Daily percentage return beside AVTR.
Daily Out/Under-Performance
Portfolio return minus AVTR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × AVTR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded AVTR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling